Pharmaceutical components used in pharmaceutical drugs and formulations are rigorously cleaned before use to ensure patient safety. Regulatory authorities expect drug manufacturers to assure clean, sterile and safe drugs enter the market. Likewise, depyrogenation is a cleansing process in which the pyrogens, including bacterial endotoxins, are either inactivated or removed. Pyrogens are fever causing substances. It is crucial step in preparing packaging solutions for injectable drug products. Pharmaceutical packaging elements such as ampules, vials and stoppers require specific depyrogenation procedures depending on the element material. The most commonly used depyrogenation techniques are dry heat and intense washing using USP and WFI water. These depyrogenated sterile empty vials available in glass and plastic material such as borosilicate. The sterile vials are usually uncapped with stoppers and aluminum seals.
Packaging of pharmaceutical products like drugs and injectable is a wide-spectrum, multifarious and complicated task. It is different from packaging of other materials as it requires scientific approach as well as precise engineering aspects and expertise to deliver the efficient product. It takes into consideration, technical aspects from a broad range of fields, including material science, physical testing, biochemistry and engineering and various others.
COVID – 19 scenario analysis:
- The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
- Industries closures, supply chain disruptions and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
- However, ongoing pandemic can unlock potential of business continuity and resilience for depyrogenated sterile empty vials market
- Increasing awareness among people for hygiene and sterile pharm products and formulations would increase creating opportunities in the market
- Plastic is again emerging as the preferred material used in packaging of pharmaceuticals and biotech formulations as it is widely available and comparatively easy for use
- Regulatory bodies, that govern the biotech and pharmaceutical industry have published guidelines regarding the sterile packaging of pharma and food products as studies have revealed that novel coronavirus can be transmitted through packaging surfaces
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
Packaging of pharmaceuticals keeps on evolving regularly, to meet the requirements and demands of the market for various track and trade features, security features and innovative designs. On the other hand, different types of packaging like primary, secondary, tertiary together with raw materials would assist to diminish the burden on supply and logistic services, distribution channels, reduce cost and improve visibility.
The governments and regulatory authorities in coalition have imposed stringent regulations and policies favorable to packaging industry. This would help the pharma companies to invest in development of packaging and introduce innovative products. The use of bio-plastics, i.e. the more sustainable plastic in packaging material is gaining traction among the pharmaceutical packaging companies. The diminished time availability of consumers with growing awareness regarding biodegradable materials for packaging of medications demands for use of environment friendly plastics.
Increased spending in R&D activities of biologics and pharmaceutical companies for innovative packaging solutions is likely to encourage market growth. Increased usage of depyrogenated sterile empty vials in plant cell culture, biological and chemical reactions, storage, photobiological studies, and sample collection is likely to boost the market growth. Adding to this, vial manufacturing process has witnessed technological advances, which enhances the storage capacity and offers accurate drug delivery mechanism for various drugs. Rise in the incidences of various infectious diseases would also fuel growth of the global depyrogenated sterile empty vials market in forthcoming years. However, the developments for alternatives of depyrogenated sterile vials is also taking place parallely, which can pose a threat to the growing market.
Rise in the prevalence of various infectious diseases
The number of infectious & non-infectious diseases has been rising simultaneously. According to the WHO, by 2018, the number of people infected with this virus is 75 million right from the beginning of this pandemic and around 32 million people have died because of this disease. Additionally, by the end of2018, around 37.9 million people were living with HIV. The ongoing COVID-19 pandemic has infected over 4.2 million people around the world causing around 290 thousand deaths. Rising number of people suffering from such infectious diseases will increase the demand for depyrogenated sterile empty vials for proper sample storage, thus accelerating the industry growth.
In addition, rise in the number of clinical laboratories for performing various diagnostic tests will also help in expanding the market. Alongside, the increasing number of compounding laboratories and research institutes as patient preference is growing towards personalized medicine in developed countries will fuel the demand for depyrogenated sterile empty vials in compounding labs. Personalized medication is offered by compounding labs for better and specific management of patient resulting in improved health outcomes.
Strategic partnerships with companies involved in pharma products packaging
Some of the key industry players implement various strategic initiatives that render competitive advantage to the companies and help in expansion of their market in various unexplored areas. Increasing number of collaborations offer innovative packaging technology which supports the market value. For instance, in March 2018, SGD Pharma introduced its Clareo range of molded glass vials for injectable drug solutions with flatter and even bottom surface that offer easy heat transfer during freeze-drying processes. This product helped company in broadening its customer base.
Likewise in April 2019, Schott AG entered into strategic collaboration with SINCAD to ensure the better quality pharmaceutical packaging. The collaboration benefitted SCHOTT as it offered SINCAD’s technologically superior vision control systems to investigate the dimensional appearance, color, accuracy and 3D laser profile of individual products. This collaboration cemented SCHOTT’s expertise in the field of inspection systems to assess the product quality.
Key benefits of the report:
- This study presents the analytical depiction of the global depyrogenated sterile empty vials industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global depyrogenated sterile empty vials market share.
- The current market is quantitatively analyzed to highlight the global depyrogenated sterile empty vials market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global depyrogenated sterile empty vials market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the Digestive Enzymes Market research report:
- Who are the leading market players active in the depyrogenated sterile empty vials market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the depyrogenated sterile empty vials market?
- What are the projections for the future that will help in taking further strategic steps?
Depyrogenated Sterile Empty Vials Market, by Material Report Highlights
| Aspects | Details |
 By Material |
|
 By Volume |
|
 By End user |
|
 By Region |
|
 Key Market Players | Stevanato Group, Thermo Fisher Scientific Inc., Radpharm Scientific, DWK Life Sciences, Nipro Pharma Packaging, Merck KGaA, Corning Incorporated, Gerresheimer, SCHOTT, VWR International, APG Pharma |
Loading Table Of Content...
